1.14.15.18 1,25-Dihydroxycholecalciferol calcitriol 8986 1.14.15.18 1,25-Dihydroxycholecalciferol calcitriol; in vivo only inhibitory in vitamin D receptor containing cells, therefore: negative feedback inhibition is mediated by the enzyme through liganded vitamin D receptor 8986 1.14.15.18 1,25-Dihydroxycholecalciferol calcitriol; decreases mRNA expression in less differentiated cells like Caco-2/AQ and COGA-1A and -1E 8986 1.14.15.18 22-oxacalcitriol vitamin D3 analogue, inhibits in vitro and in vivo 108194 1.14.15.18 25-hydroxy-3-deoxy-2-oxavitamin D3 vitamin D3 analogue, competitive inhibition 108199 1.14.15.18 25-hydroxydihydrotachysterol3 - 108200 1.14.15.18 25-hydroxyvitamin D2 CYP27B1 shows inhibition when substrate concentrations in the membrane are greater than 4 times Km, more pronounced with 25-hydroxyvitamin D3 than with 25-hydroxyvitamin D2 12134 1.14.15.18 25-hydroxyvitamin D3 CYP27B1 shows inhibition when substrate concentrations in the membrane are greater than 4 times Km, more pronounced with 25-hydroxyvitamin D3 than with 25-hydroxyvitamin D2 4387 1.14.15.18 3-deoxy-2-oxa-9(11)-didehydro-25-hydroxyvitamin D3 vitamin D3 analogue, competitive inhibition 108297 1.14.15.18 A-homo-3-deoxy-2-oxa-25-hydroxyvitamin D3 vitamin D3 analogue, competitive inhibition 108640 1.14.15.18 Aminoglutethimide enzyme of intact mitochondria 15629 1.14.15.18 antimycin A - 1042 1.14.15.18 antimycin A inhibition occurs with succinate reaction support, no inhibition together with malate 1042 1.14.15.18 antimycin A higher inhibition rate with succinate as electron donor than with malate 1042 1.14.15.18 antimycin A no inhibition of hydroxylation 1042 1.14.15.18 Ca2+ - 15 1.14.15.18 clotrimazole in vivo in MCF-7 cells 1496 1.14.15.18 CN- - 159 1.14.15.18 CO 50% O2/50% CO2 incubation atmosphere 176 1.14.15.18 CO - 176 1.14.15.18 CO no inhibition 176 1.14.15.18 cyanide - 118 1.14.15.18 dinitrophenol - 4519 1.14.15.18 dinitrophenol higher inhibition rate with malate as electron donor than with succinate 4519 1.14.15.18 diphenyl-p-phenylenediamine - 29952 1.14.15.18 diphenyl-p-phenylenediamine no inhibition 29952 1.14.15.18 Epidermal growth factor decreases mRNA expression in less differentiated cells like Caco-2/AQ and COGA-1A and -1E; i.e. EGF 1865 1.14.15.18 ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid - 108931 1.14.15.18 Glutethimide - 93511 1.14.15.18 itraconzole - 14051 1.14.15.18 ketoconazole - 483 1.14.15.18 metapyrone - 13195 1.14.15.18 Metyrapone - 990 1.14.15.18 Metyrapone enzyme of intact mitochondria 990 1.14.15.18 Mn2+ - 11 1.14.15.18 additional information inhibition by renal mitochondrial protein kinase-catalyzed phosphorylation 2 1.14.15.18 additional information no inhibition with Ba2+, acetate, sulfate 2 1.14.15.18 additional information overview, inhibitory potency of several vitamin D3 analogues 2 1.14.15.18 additional information the enzyme is not affected by cardiolipin and dilauroylphosphatidylcholine 2 1.14.15.18 additional information inhibitory effects of the MEK inhibitor PD98059, p38 MAPK inhibitor SB203580, and JNK inhibitor SP600125 on the IFNgamma/PMA-induced or IFNgamma/LPS-induced 1alpha-hydroxylase mRNA expression in THP1 cells, overview 2 1.14.15.18 Natural inhibitors from rat and pig tissues 21036 1.14.15.18 Natural inhibitors rat plasma 25-hydroxyvitamin D3 binding protein 21036 1.14.15.18 Natural inhibitors from rat serum 21036 1.14.15.18 Natural inhibitors vitamin D binding protein 21036 1.14.15.18 oligomycin - 2150 1.14.15.18 p-chloromercuribenzoate - 43 1.14.15.18 p-Trifluoromethoxyphenylhydrazone - 94641 1.14.15.18 phosphate - 16 1.14.15.18 phosphate no inhibition 16 1.14.15.18 rotenone no inhibition of hydroxylation 777 1.14.15.18 rotenone - 777 1.14.15.18 Sr2+ - 338 1.14.15.18 sucrose hypertonic 55 1.14.15.18 Tris-chloride buffer - 95259 1.14.15.18 vitamin D3 - 2767